Fosaprepitant and aprepitant: an update of the evidence for their place in the prevention of chemotherapy-induced nausea and vomiting

INTRODUCTION: The selective neurokinin-1 receptor antagonist aprepitant is effective in the treatment of acute and delayed chemotherapy-induced nausea and vomiting (CINV) associated with both moderately and highly emetogenic chemotherapy. Fosaprepitant has been developed as an intravenous prodrug of...

Descripción completa

Detalles Bibliográficos
Autores principales: Langford, Patrick, Chrisp, Paul
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963924/
https://www.ncbi.nlm.nih.gov/pubmed/21042544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963924/
https://www.ncbi.nlm.nih.gov/pubmed/21042544

Ejemplares similares